Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab

被引：3

作者：

Bersanelli, Melissa ^{[1
]}

Gnetti, Letizia ^{[2
]}

Azzoni, Cinzia ^{[2
]}

Bottarelli, Lorena ^{[2
]}

Sverzellati, Nicola ^{[3
]}

Campanini, Nicoletta ^{[2
]}

Varotti, Elena ^{[2
]}

Corrado, Michele ^{[3
]}

Parziale, Raffaele ^{[3
]}

Rapacchi, Elena ^{[1
]}

Caruso, Giuseppe ^{[1
]}

Leonardi, Francesco ^{[1
]}

Silini, Enrico Maria ^{[2
]}

Buti, Sebastiano ^{[1
]}

机构：

[1] Univ Hosp Parma, Med Oncol, Via Gramsci 14, I-43126 Parma, Italy

[2] Univ Hosp Parma, Pathol Anat Unit, Via Gramsci 14, I-43126 Parma, Italy

[3] Univ Hosp Parma, Radiol Unit, Via Gramsci 14, I-43126 Parma, Italy

来源：

IMMUNOTHERAPY | 2018年 / 10卷 / 09期

关键词：

FHIT; loss of heterozygosity; renal cell carcinoma; SPORADIC BREAST-CANCER; CLEAR-CELL CARCINOMA; MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; OVARIAN-CANCER; BRCA2; VHL; 3P; TUMORIGENESIS; GUIDELINES;

D O I：

10.2217/imt-2017-0160

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Aim: We studied the possible clinical significance of loss of heterozygosity (LOH) at key tumor suppressor genes loci in advanced renal cancer patients treated with nivolumab. Methods: LOH study was performed on 3p14.2 (FHIT gene); 3p21.3-21.2; 9p21 (BDMF gene); 9p22 (SH3GL2 gene). Results: Of 12 patients, 8 (67%) had LOH. The most affected gene was FHIT. All five patients with LOH at FHIT locus had good outcome, mean progression free survival of 6.8 months. The patients LOH negative at FHIT locus had mean progression free survival of 4 months, 67% were treatment refractory. Overall, 75% of patients with LOH of at least one gene had benefit; 75% of LOH negative cases were refractory. Conclusion: LOH at key tumor suppressor genes should be further investigated as predictive for immunotherapy.

引用

页码：743 / +

页数：11

共 50 条

[1] Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab (vol 10, pg 743, 2018)
Bersanelli, Melissa
Gnetti, Letizia
Azzoni, Cinzia
Bottarelli, Lorena
Sverzellati, Nicola
Campanini, Nicoletta
Varotti, Elena
Corrado, Michele
Parziale, Raffaele
Rapacchi, Elena
Caruso, Giuseppe
Leonardi, Francesco
Silini, Enrico Maria
Buti, Sebastiano
IMMUNOTHERAPY, 2018, 10 (14) : 1287 - 1288
[2] LOSS OF HETEROZYGOSITY OF TUMOR-SUPPRESSOR GENES IN TESTIS CANCER
PENG, HQ
BAILEY, D
BRONSON, D
GOSS, PE
HOGG, D
CANCER RESEARCH, 1995, 55 (13) : 2871 - 2875
[3] MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY OF TUMOR SUPPRESSOR GENES IN BOSNIAN PATIENTS WITH SPORADIC COLORECTAL CANCER
Hadaziavdic, Vesna
Pavlovic-Calic, Nada
Eminovic, Izet
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2008, 8 (04) : 313 - 321
[4] Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma
Yip, Linwah
Seethala, Raja R.
Nikiforova, Marina N.
Nikiforov, Yuri E.
Ogilvie, Jennifer B.
Carty, Sally E.
Yim, John H.
SURGERY, 2008, 144 (06) : 949 - 954
[5] Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer
Sturlan, S
Kapitanovic, S
Kovacevic, D
Lukac, J
Spaventi, S
Spaventi, R
Pavelic, K
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (03): : 316 - 321
[6] Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer
Sanda Šturlan
S. Kapitanović
Duje Kovačević
Josip Lukač
Šime Spaventi
Radan Spaventi
Krešimir Pavelić
Journal of Molecular Medicine, 1999, 77 : 316 - 321
[7] Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer
Choi, Chel Hun
Lee, Kyung-Mee
Choi, Jung-Joo
Kim, Tae-Joong
Kim, Woo Young
Lee, Jeong-Won
Lee, Sun-Joo
Lee, Je-Ho
Bae, Duk-Soo
Kim, Byoung-Gie
CANCER LETTERS, 2007, 255 (01) : 26 - 33
[8] Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma DISCUSSION
Clark, Orlo H.
Yip, Linwah
Singh, Bhuyanejh
Politz, Doug
Sosa, Julie Ann
SURGERY, 2008, 144 (06) : 954 - 955
[9] Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence
Thiagalingam, S
Foy, RL
Cheng, KH
Lee, HJ
Thiagalingam, A
Ponte, JF
CURRENT OPINION IN ONCOLOGY, 2002, 14 (01) : 65 - 72
[10] Loss of heterozygosity of major tumor suppressor genes in invasive ductal carcinomas
Byun, Woo Seok
Park, Chan Heun
Cho, Seong Jin
Ahn, Hye Gyung
Nam, Eun Sook
Cha, Hee Jung
Kim, Kwan Suk
JOURNAL OF BREAST CANCER, 2007, 10 (01) : 68 - 76

← 1 2 3 4 5 →